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a b s t r a c t
The integration of multiple morphogenic signalling pathways and transcription factor networks is
essential to mediate neural crest (NC) cell induction, delamination, survival, stem-cell properties, fate
choice and differentiation. Although the transcriptional control of NC development is well documented
in mammals, the role of post-transcriptional modiﬁcations, and in particular ubiquitination, has not been
explored. Here we report an essential role for the ubiquitin ligase Nedd4 in cranial NC cell development.
Our analysis of Nedd4/ embryos identiﬁed profound deﬁciency of cranial NC cells in the absence of
structural defects in the neural tube. Nedd4 is expressed in migrating cranial NC cells and was found to
positively regulate expression of the NC transcription factors Sox9, Sox10 and FoxD3. We found that in
the absence of these factors, a subset of cranial NC cells undergo apoptosis. In accordance with a lack of
cranial NC cells, Nedd4/ embryos have deﬁciency of the trigeminal ganglia, NC derived bone and
malformation of the craniofacial skeleton. Our analyses therefore uncover an essential role for Nedd4 in a
subset of cranial NC cells and highlight E3 ubiquitin ligases as a likely point of convergence for multiple
NC signalling pathways and transcription factor networks.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Neural crest (NC) cells are a transient population of stem-cells
that arise from neuroepithelial precursors during early embryonic
development to generate a wide spectrum of derivatives. Cranial
NC cells arise between the posterior forebrain and posterior
hindbrain and migrate into the facial primordia to generate the
vast majority of the vertebrate head including the cranial ganglia,
connective tissue, tendons, osteoblasts, chondrocytes and mela-
nocytes (Le Douarin et al., 2004; Osumi-Yamashita et al., 1994).
Underscoring the critical importance of this cell type is the high
prevalence of congenital craniofacial birth defects such as cleft lip
and/or palate and Digeorge Syndrome that arise from cranial NC
cell deﬁciencies (Cordero et al., 2010).
The understanding of NC cell development at the molecular level is
heavily biased toward the role of transcription factor networks acting
downstream of morphogen signalling (Steventon et al., 2005). NC
induction is initiated at the interface of the neural plate and non-
neural ectoderm through the combined activity of several morpho-
gens such as BMPs, FGFs and Wnts that induce expression of NC cell
specifying transcription factors including Snail, Sox10, Sox9 and
FoxD3. These transcription factors not only promote an epithelial-to-
mesenchymal transition by altering expression of cell adhesion and
morphology molecules, they also play essential roles in the early
maintenance of NC cell identity, NC cell survival and NC stem-cell
properties (Steventon et al., 2005). Notably, many of these transcrip-
tion factors are down-regulated after the initial stages of NC cell
delamination and their early migration away from the neural tube, but
are later up-regulated to play essential roles in NC-derived tissue
morphogenesis.
The HMG box transcription factors Sox9 and Sox10 are initially
expressed in most NC cells to promote delamination from the
neural tube, however, both play disparate roles in later stages of
NC development. Sox9 is down-regulated in cranial NC cells as
they migrate into the facial primordia at E9.5 and later is up-
regulated (from E12.5 onwards) to act as a master regulator in
mesenchymal condensations that will form cartilage (Akiyama
et al., 2002; Bi et al., 2001; Steventon et al., 2005). In its absence
NC cells apoptose either during or shortly after delamination
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resulting in a reduced number of NC cells that will form the
craniofacial skeleton. As a consequence of NC hypoplasia and
aberrant cartilage differentiation, Sox9 deﬁcient embryos have
profound craniofacial defects (Cheung et al., 2005). Sox10 expres-
sion is initially maintained in NC cells of a neuroglial fate and is
required for NC stem-cell self-renewal and multipotentiality (John
et al., 2011; Kim et al., 2003). Sox10 deﬁcient mice have been
shown to have widespread defects in many NC derivatives that
result from precocious NC cell death prior to differentiation
(Kapur, 1999; Sonnenberg-Riethmacher et al., 2001; Southard-
Smith et al., 1998). The forkhead transcription factor FoxD3 begins
to be expressed prior to delamination, is maintained in migrating
NC cells, but is later down-regulated during differentiation into
most derivatives (Labosky and Kaestner, 1998). An essential role
for FoxD3 in early NC cell maintenance and survival has been
deﬁned through loss-of-function studies in mice (Mundell and
Labosky, 2011; Teng et al., 2008). Consequently, mouse embryos
lacking FoxD3 in NC cells have profound craniofacial defects (Teng
et al., 2008). Ex vivo studies have also shown that FoxD3 is
required to direct fate choices of NC cells and to regulate NC
stem-cell self-renewal and multipotentiality (Mundell and
Labosky, 2011). The signalling pathways that regulate these
transcription factors and how these transcriptional networks are
coordinated is ill deﬁned.
The ubiquitin pathway plays critical roles in most cellular
processes by regulating proteosomal- and lysosomal-mediated
protein degradation, and also by modulating the function of target
substrates by altering their subcellular localisation or biochemical
properties (reviewed in (Rotin and Kumar, 2009)). The ubiquitina-
tion process requires three enzymes: the E1 enzyme initially
activates ubiquitin, E2 enzymes facilitate the transfer of activated
ubiquitin to substrates recognised by one of many E3 ubiquitin
protein ligases (for a detailed review we refer readers to (Kerscher
et al., 2006)). In this manner, E3 ubiquitin ligases provide substrate
speciﬁcity and are essential in identifying which proteins are
targeted for ubiquitination. Their ability to recognise multiple
targets provides an ideal mechanism through which several
signalling pathways can converge. To date, the role of E3 ubiquitin
ligases and ubiquitination in mammalian NC cell development has
not been explored.
Here we uncover a hitherto unknown role for the founding
member of the HECT family of E3 ubiquitin ligases, Nedd4 (neural
precursor cell expressed developmentally down-regulated)
(Kumar et al., 1997), in mouse NC cell development. Nedd4 has a
number of putative substrates with known roles in NC cell
development identiﬁed through in vitro studies, including Ptch1
(Lu et al., 2006), FGFR1 (Persaud et al., 2009), receptor-regulated
SMAD1 (Kim et al., 2011) and ErbB4 (Zeng et al., 2009). In contrast,
there is limited knowledge of the roles and substrates of Nedd4
in vivo: in mice it regulates Rap2A (Kawabe et al., 2010) and PTEN
(Christie et al., 2011; Drinjakovic et al., 2010) to control neurite
development and axonal branching, regulates Thrombospondin-1
to control cardiovascular development (Fouladkou et al., 2010),
and positively regulates IGF-1R signalling to control embryonic
growth (Cao et al., 2008).
Our functional analyses of Nedd4/ embryos and Nedd4-
deﬁcient NC cells now highlights an essential role for Nedd4 in
the maintenance of a subset of cranial NC cells and the promotion
of stem-cell like properties. Nedd4 is expressed in cranial NC cells
during their migration from the neural tube toward their ﬁnal
destinations in the anterior regions of the head. In the absence of
Nedd4, there is a striking hypoplasia of cranial NC cells emigrating
from the posterior forebrain, midbrain and rostral hindbrain. Our
in vivo and ex vivo analyses suggest that Nedd4-deﬁcient cranial
NC cells form normally, but undergo aberrant apoptosis during
their migration away from the neural tube. Accordingly, the
trigeminal ganglia and craniofacial skeleton of Nedd4 / embryos
is dramatically affected. To understand the origin of this defect we
analysed the expression of the core NC cell transcription factors.
Our analyses show that Snail, Sox9, Sox10 and FoxD3 are rapidly
downregulated following Nedd4 knockdown, providing insight to
the molecular defects underpinning NC cell death, loss of stem-cell
like self-renewal capacities and cranial NC hypoplasia. Taken
together, our ﬁndings identify Nedd4 as a key E3 ubiquitin ligase
in modulating transcription factor networks in a subset of cranial
NC cells and support a role for Nedd4 in the development of the
ectomesenchyme and neuroglial cranial NC cell lineages.
Results
Nedd4 / mice have craniofacial defects
Our analysis of Nedd4 deﬁcient embryos revealed that these
mice have severe craniofacial defects with full penetrance (8/8
Nedd4 / vs. 0/8 wildtype). Embryonic day (E) 15.5 Nedd4 /
embryos exhibit a pronounced forehead and displacement of the
tongue from the oral cavity (Fig. 1A). Staining of bone and cartilage
at E15.5 with Alizaran red and Alcian blue revealed that the
majority of NC and paraxial mesoderm derived cartilage was
present in Nedd4/ embryos, indicating that the early stages of
cartilage condensation are normal in mutant embryos (Fig. 1C). At
E17.5, wholemount staining revealed that many cranial bones
were either absent or severely hypoplastic in Nedd4/ embryos
(Fig. 1C). While the bulk of the cranial skeleton arises from NC cell
origin, the caudal regions of the skull, including the otic capsule,
the occipital and part of the sphenoid bones arise from paraxial
mesoderm.
Our analysis at E17.5 found that cranial bones of NC cell origin
were affected more than bone of paraxial mesoderm origin with
gross defects of the mandible and maxilla, and absence of all or
part of the premaxillary, frontal and tympanic bones (Fig. 1C).
Nedd4 / embryos also display a cleft palate, which results as a
failure of the palatal shelves to fuse (Fig. 1B), and subsequently the
palatal bone is absent at E17.5 (Fig. 1C). Analysis of bone formation
by microCT scans produced skeletal models consistent with the
bone stains showing that bone density in the mandible, maxilla,
premaxilla, frontal, tympanic and palatal bones were reduced in
Nedd4 / embryos (n¼3; Supplemental Fig. S1A).
While Nedd4/ embryos are signiﬁcantly smaller than their
wildtype littermates due to an IGF-dependent growth defect (Cao
et al., 2008), the absence or deﬁciency of the cranial bones is
unlikely to be the sole consequence of a developmental delay.
Strong evidence for this comes from normal formation of cartilage
at E15.5, including the nasal capsule, Meckel's cartilage, otic
capsule and frontal cartilage (Fig. 1C). At E17.5 non-NC derived
bone, albeit reduced in size, was affected less than the NC-derived
bone with only mild reductions in ossiﬁcation of the exoccipital
(eo) and basioccipital (boc) bones in the head (Fig. 1C), and the
vertebrae, ribs and limbs in the body (Supplemental Fig. S1A and B).
To quantify the deﬁciency of the craniofacial skeletonwe completed
bone mass calculations of microCT 3D models and normalised this
to formation of the humerus. Our calculations identiﬁed develop-
mental defects in both NC and mesoderm derived bone. However,
the defects in NC derived bone (reduction of 6572%, n¼3) far
outweighs the defects in mesoderm derived bone (reduction of
25%78%, n¼3) in E17.5 Nedd4 / embryos (see Supplemental
Fig. S1A). Our data therefore suggests that Nedd4 is required for
craniofacial development, and in particular, for NC cell bone
formation.
To deﬁne the origin of these cranial defects, bone and cartilage
were analysed at E12.5 in Nedd4 / embryos, a time when these
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tissue types are beginning to condense in the cranium. RunX2 is a
marker of cells that will form bone, while Sox9 labels cells that are
destined to form cartilage (Mori-Akiyama et al., 2003). Frontal
sections through the maxillary/mandibular region of E12.5
embryos containing NC derived bone and cartilage revealed that
Sox9 protein was present at comparable levels in control and
Nedd4 / embryos (Fig. 1D, lower panels; see Supplemental
Fig. S2 for plane of sectioning), indicating that cartilage induction
is normal in mutant embryos. This ﬁnding is consistent with
the cartilage formation seen at E15.5 and E17.5 (see Fig. 1C).
Fig. 1. Craniofacial phenotype of Nedd4 / embryos. (A) Control and Nedd4/ embryos at E15.5. Defects in Nedd4/ embryos are indicated by arrowheads, and include
pronounced forehead and displacement of the tongue from the mouth. (B) Frontal sections through the head of E15.5 control and Nedd4/ embryos stained with
hematoxylin and eosin, demonstrating cleft palate in mutant embryos. p, palate; ps, palatal shelf; and t, tongue. Scale bar¼500 μm. (C) Skulls of E15.5 and E17.5 control and
Nedd4/ embryos stained for bone (Alizarin red) and cartilage (Alcian blue). bas, basisphenoid; boc, basioccipital; eo, exoccipital; fb, frontal bone; fc, frontal cartilage; h,
hypophyseal; lo, lamina obturans; md, mandible; mk, Meckel's cartilage; mx, maxillary; nc, nasal capsule; oc, otic capsule; pal, palatal; pmx, premaxillary; pn, paranasal
cartilage; ppmx, palatal process maxillary; ptg, pterygoid; tr, trabecular cartilage; and tym, tympanic. Scale bar¼1 mm. (D) Frontal sections through the head of E12.5 control
and Nedd4/ embryos. Adjacent serial sections were analysed for RunX2 mRNA expression, and Sox9 protein expression. All in situ sections were developed for the same
time period and all images were taken at the same exposure. j, lower jaw; ns, nasal septum; and t, tongue. Scale bars¼400 μm.
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In contrast, analysis of adjacent serial sections for RunX2 mRNA
expression by in situ hybridisation revealed that induction of bone
tissue was severely affected in Nedd4 / embryos, with minimal
expression of RunX2 detectable in mutant embryos compared to
controls (Fig. 1D, upper panels and Supplemental Fig. S2). This
suggests that the absence of bone at E17.5 is due to defects arising
at an earlier time point in craniofacial development.
We next asked whether additional NC derivatives may be
affected in the absence of Nedd4 by analysing the formation of
the paired cranial ganglia that are populated by cranial NC in
addition to cells from neurogenic placodes (Begbie and Graham,
2001). To identify NC derived glia and Schwann cells we assessed
cadherin 6 expression in E10.5 embyros by in situ hybridisation
(Fig. 2). Consistent with our previous analyses we found that
Nedd4/ embryos were smaller than controls. Wholemount
staining of cadherin 6 revealed that the trigeminal ganglia
(v) was notably hypoplastic in all Nedd4 / embryos examined
(n¼3). Albeit reduced in size, our analysis was unable to identify
any gross defects in the facioacoustic (vii/iii), glossopharyngeal or
vagal ganglia (Fig. 2A). Labelling of neuronal cell bodies and their
axonal projections with an antibody to Beta-III tubulin further
conﬁrmed this deﬁciency of the trigeminal ganglia (Fig. 2B).
Cadherin 6 staining of Schwann cells along the major nerve
branches and Beta-3 tubulin staining of axons indicates that
sensory neuronal patterning and axonal navigation are preserved
in Nedd4 / embryos. Nedd4/ embryos therefore have multiple
yet speciﬁc defects in several cranial NC derivatives including the
trigeminal ganglia and craniofacial bone.
Nedd4 / embryos are deﬁcient in cranial NC cells
Given the prominent deﬁciency of a subset of cranial NC cell
derivatives in Nedd4/ embryos, we investigated the expression
of Nedd4 during early development. In the embryonic mouse head,
cranial NC cells of the ectomesenchyme and neuroglial lineages
delaminate from the caudal forebrain, midbrain, and rostral
hindbrain from E7.5-9.5 and migrate along well deﬁned paths to
form the paired cranial ganglia and the mesenchyme of the facial
primordia, including the frontonasal prominence, maxillary pro-
minence and mandibular prominence (Kontges and Lumsden,
1996; Osumi-Yamashita et al., 1994). Upon reaching the facial
primordia, cranial NC cells receive inductive signals from sur-
rounding epithelium and mesoderm to proliferate and differenti-
ate into distinct craniofacial elements (Helms and Schneider,
2003; Santagati and Rijli, 2003).
Fig. 2. Nedd4/ embryos have deﬁciency of the trigeminal ganglia. (A) In situ hybridisation for cadherin 6 in E10.5 control and Nedd4/ embryos. The trigeminal ganglia
(v) is severely hypoplastic in Nedd4/ embryos (arrowhead). Note that the trigeminal ganglia are similar in size to the facioacoustic (vii/iii) ganglia in Nedd4/ embryos
but over twice the size in controls. (B) Confocal images of wholemount control and Nedd4/ E10.5 embryos stained with anti-Beta-III tubulin antibody. Beta-III tubulin
staining conﬁrms the abnormality in the trigeminal ganglia (arrowhead). e, eye; pa1 and pa2, pharyngeal arches 1 and 2. Scale bar¼200 μm.
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Nedd4 expression was analysed by X-gal staining of Nedd4þ /LacZ
heterozygous embryos (Cao et al., 2008). Nedd4 is broadly
expressed in the facial primordia during early stages of develop-
ment from E9.0 to E10.5 (Fig. 3A). Our analysis further shows that
Nedd4 expression is enriched in the cranial NC cells entering the
frontonasal prominence (fnp), maxillary prominence (mx) and
mandibular prominence (md) and in NC cells emigrating from
rhombomere (r)1, r2 and r4 in the hindbrain (Fig. 3A). Co-staining
of longitudinal and transverse E9.5 sections through the head with
the NC protein marker p75 revealed co-localisation of Nedd4
expression in the NC cells, especially those emigrating from r1
and r2 (Fig. 3B).
Fig. 3. Nedd4 is expressed in NC cells during development. (A) Wholemount staining of Nedd4þ /LacZ embryos at E9.0, E9.5 and E10.5 with X-gal to reveal expression of
β-galactosidase in blue. In these heterozygous embryos, LacZ is expressed under the control of the native Nedd4 promoter. β-galactosidase (and hence Nedd4) shows enriched
expression in the frontonasal process (fnp), maxillary process (mx) and mandibular process (md), ectomesenchyme below rhombomeres 1, 2 and 4 (r1, r2 and r4), and the
second branchial arch. (B) Longitudinal (top panel) and transverse (middle and bottom panel) sections through E9.5 Nedd4þ /LacZ embryos. Sections were co-stained with
X-gal and with anti-p75 antibody. Co-localisation of β-galactosidase and p75 is evident, especially in the mesenchyme below r2, indicating that Nedd4 is expressed in cranial
NC cells.
Fig. 4. Nedd4 / embryos have cranial NC cell defects. (A) In situ hybridisation for Sox10 from E8.25 to E9.5 in control and Nedd4/ embryos. (B) Transverse sections
through the anterior regions of E8.5 and rhombomere 2 (r2) region of E9.0 embryos. (C) Confocal imaging of E9.5 control and Nedd4/ embryos stained with anti-p75
antibody in wholemount (upper panels) and transverse sections through r2 (lower panels). Deﬁciencies in NC cells were evident in the mesenchyme below r1 and r2
(arrowheads), the frontonasal process (arrows), maxillary process (wavy arrow) and mandibular process (Δ). e, eye and ov, otic vesicle. Scale bar¼500 μm.
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We hypothesised that some of the craniofacial and neuroglial
defects seen in older Nedd4/ embryos may be due to defects in
the early processes of NC cell development, including speciﬁca-
tion, maintenance/self-renewal, and/or migration. To investigate
this, we analysed expression of the NC cell marker Sox10 by in situ
hybridisation (Fig. 4A and B), and p75 by wholemount antibody
staining (Fig. 4C and Fig. 6A and B) in Nedd4 / embryos at E8.25-
9.5. Our analysis of wholemount embryos (Fig. 4A) and corre-
sponding transverse sections (data not shown) was unable to
identify notable defects in Sox10 expression at the earliest time
point examined (E8.25, WT, n¼4; KO, n¼4). At later time points
(E8.5, n¼6; E9.0, n¼4; E9.5, n¼10) we noticed a marked reduc-
tion in the number of Sox10 and p75 positive cells in the facial
primordia in all Nedd4 deﬁcient embryos that was particularly
evident in the frontonasal (arrow), maxillary (curved arrow) and
distal mandibular prominences, and in the stream of NC cells
emanating from r1 and r2 (arrowhead) that give rise to the
trigeminal ganglia. At E9.5 Sox10 staining revealed reduced
expression in the r2/r4 NC streams and otic vesicle in the absence
of notable differences in caudal regions of the embryo (Fig. 4B
asterisk). Transverse sections further demonstrate the reduction of
NC cells in the anterior regions of E8.5 Nedd4 / embryos (Fig. 4B
Fig. 5. Hindbrain patterning and NC speciﬁcation is normal in Nedd4/ embryos. (A) Wholemount in situ hybridisation of control and Nedd4/ embryos at E8.5 for Crabp1
which marks r4, r5 and r6, HoxB1 which marks r4, and Krox20 which marks r3 and r5. Staining was comparable between control and Nedd4/ embryos, indicating that
hindbrain patterning is normal. Scale bar¼250 μm. (B) Wholemount in situ hybridisation of control and Nedd4/ embryos at E9.5 for Fgf8 which marks the midbrain-
hindbrain boundary (mhb). Staining was comparable between control and Nedd4/ embryos, indicating that formation of the mhb is normal. Scale bar¼250 μm.
(C) Wholemount in situ hybridisation for Wnt1 which marks the mhb and dorsal neural tube is required for induction of NC cells. Staining was comparable between control
and Nedd4/ embryos, indicating that speciﬁcation of the NC is occurring normally in these embryos. Scale bar¼250 μm.
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arrowhead) and in the mandibular prominence of E9.0 Nedd4 /
embryos (Fig. 4BΔ). P75 staining conﬁrmed signiﬁcant reductions
of NC cells in the r2 stream at E9.5 but showed near normal levels
of NC cells in the r4 stream (Fig. 4C). Our data therefore indicate
that Nedd4 / embryos have reduced numbers of cranial NC cells
of the ectomesenchyme lineage in the rostral regions of the head
and of the neuroglial lineage giving rise to the trigeminal ganglia.
The deﬁciency in NC cells observed in Nedd4 / embryos does
not appear to result from defects in midbrain/hindbrain segmen-
tation or patterning. In situ hybridisation analysis revealed that
Crabp1 (n¼2), HoxB1 (n¼2) and Krox20 (n¼4) expression is
unaffected in Nedd4 / embryos at E8.5 (Fig. 5A). The midbrain-
hindbrain boundary also forms normally at E9.5 as revealed by
Fgf8 (n¼4) andWnt1 (n¼3) expression (Fig. 5B and C). Our marker
analysis further suggests that NC cell speciﬁcation is normal in
Nedd4/ embryos, as expression of the NC induction factor Wnt1
is unchanged (Fig. 5C). Taken together, these data suggest that the
deﬁciency of a subset of cranial NC cells in Nedd4/ embryos
arises from a defect in subsequent stages of NC cell development.
Loss of Nedd4 induces apoptosis in a subset of cranial NC cells
We hypothesised that the reduction in number of cranial NC cells
in Nedd4 / embryos may be due to an increase in cell death.
To investigate this we adopted two complimentary approaches to
detect apoptotic cells in Nedd4 / embryos, TUNEL staining (Fig. 6)
and immunostaining of cleaved-caspase-3 (Supplemental Fig. S3).
Both approaches revealed an increase in apoptotic cranial NC cells in
Nedd4 / embryos. At E8.5, increased cell death was observed in NC
cells below the forebrain, midbrain and hindbrain in regions corre-
sponding to the frontonasal (arrow), maxillary (curved arrow) and
mandibular prominences (arrowhead). (Fig. 6A and Supplemental Fig.
S3A). Consistent with previous reports we also found that the two
methods had overlapping but distinct staining patterns (i.e. cleaved-
caspase-3 was present in approximately 50% of TUNEL positive cells
(SW and QS, data not shown)) which may reﬂect the differing stages
of the apoptosis cascade that these reagents detect (Duan et al., 2003).
Transverse sections through the forebrain/midbrain and rostral hind-
brain conﬁrmed the localisation of these p75 positive apoptotic NC
cells in the facial primordia, and also revealed aberrant cell death in
the neuroepithelium (asterisk) (Fig. 6A). Aberrant cell death was also
evident in the facial primordia at E9.5 (Fig. 6B). Co-staining with p75
identiﬁed apoptotic cells within migrating NC cells (Fig. 6B) and in
regions directly adjacent to the stream of NC cells emanating from r1
and r2 (Fig. 6B and Supplementary Fig. S3B). Transverse sections
reveal the localisation of these apoptotic cells in the neuroepithelium
(asterisk) and NC derived ectomesenchyme in the facial primordia and
1st pharyngeal arch (Fig. 6B and Supplementary Fig. S3C). To conﬁrm
an increase in cell death in Nedd4 / embryos, we counted the total
number of TUNEL positive NC cells and neuroepithelial precursor cells
Fig. 6. Loss of Nedd4 induces NC apoptosis. (A) Wholemount (top panel) and transverse sections (middle and bottom panel) of control and Nedd4 / embryos at E8.5
stained with TUNEL TMR Red assay and anti-p75 antibody. Increased cell death was observed in the frontonasal process (arrow), mesenchyme below rhombomere 1 and
rhombomere 2 (r2) (arrowhead), and maxillary prominence (wavy arrow) in mutant embryos. Transverse sections conﬁrm that this cell death was evident in the p75-
positive stream of NC cells (middle and bottom panel) and identiﬁed increased cell death in the neuroepithelial precursors of NC cells (*). (B) Wholemount and section
staining of E9.5 embryos as in (A). Cell death was apparent in the same regions as for E8.5 embryos. Scale bar¼200 μm. (C) Total numbers of TUNEL positive NC cells or
neuroepithelial cells in the neural tube were counted from transverse sections of E8.5 embryos. (D) Primary NC cells were stained with anti-cleaved-caspase-3 antibody 12 h
after knockdownwith either control or Nedd4 speciﬁc siRNAs. Scale bar¼200 μm. (E) Apoptotic cells were counted and expressed as a percentage of total DAPI positive cells.
Error bars represent standard error of the mean (SEM) and the P-value is based on a t-test with * representing Po0.05 and ** representing P¼0.0055.
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in transverse sections through the anterior regions of the head (i.e. all
sections anterior to the r4 stream) in E8.5 embryos. Our analysis
demonstrates that there is a signiﬁcant 6-fold increase in NC cell death
and a 2-fold increase in neuroepithelial cell death in Nedd4/
embryos compared to wildtype controls (n¼4, *¼po0.05; Fig. 6C).
An increase in NC cell death, and of their neuroepithelial precursors in
the dorsal neural tube, may therefore explain the reduction of NC cells
seen in Nedd4/ embryos (see Fig. 4A and C). The reduction in NC
cell number cannot be explained by a reduction in cell proliferation, as
phospho-histone H3 staining was similar in the NC cells of mutant and
control embryos (n¼3, PHH3 positive NC cells in wildtype 0.016/mm2
compared to Nedd4 / 0.017/mm2, Supplementary Fig. S4).
In order to investigate the molecular defects underpinning cell
death in Nedd4 deﬁcient cranial NC cells, we turned to an ex vivo
model of NC cell development. In this model, primary mouse NC cells
are grown and passaged from neural tube explants of wildtype E8.5-
9.5 embryos. A murine-derived transformed NC cell-line, NC-U-10-K
(Murphy et al., 1991) was also utilised to validate these analyses.
siRNAs speciﬁc to Nedd4 were used to knockdown Nedd4 protein
expression in both primary and NC-U-10-K cells and directly com-
pared to siRNA controls. Complete knockdown of Nedd4 was con-
ﬁrmed by western blot and quantitative PCR analysis (Supplemental
Fig. S5A and B). Staining of primary NC cells with anti-cleaved-
caspase-3 antibodies 12 h after Nedd4 knockdown revealed a sig-
niﬁcant increase in cell death of approximately 2-fold in cells treated
with Nedd4 siRNA (n¼5, p¼0.0055; Fig. 6D and E). Dynamic changes
in cell death following Nedd4 knockdown were also assayed in
primary NC cells by live cell imaging. Our analysis identiﬁed a
reduction in cell growth that was accompanied by an increase in
apoptosis as determined using a ﬂuorescent activated caspase-3/7
kinetic assay (n¼5; Supplemental Fig. S5C). The increase in apoptosis
in NC cells depleted of Nedd4 protein is in strong agreement with our
in vivo data that demonstrates heightened cell death in cranial NC cells
migrating in the facial primordia in Nedd4 / mouse embryos. Our
in vitro studies in primary NC cells also help to support a role for
Nedd4 protein cell-autonomously in the cranial NC. Combined with
our expression analysis of Nedd4 which demonstrates enriched
expression in the cranial NC, our data strongly suggest that Nedd4 is
required to maintain survival of a subset of cranial NC cells.
Nedd4 maintains expression of NC specifying transcription factors
The concerted activity of several transcription factors including
Sox9, Sox10, Snail and FoxD3 promote speciﬁcation of bona ﬁde NC
cells and their subsequent delamination away from the neural tube.
In addition, these core transcription factors are essential for main-
tenance of NC cell identity and cell survival both during and post
delamination (Steventon et al., 2005). Given our ﬁndings of increased
death in cranial NC cells and their neuroepithelial precursors, reduced
expression of Sox10 in vivo, hypoplastic trigeminal ganglia and the lack
of bone in Nedd4 / embryos, we hypothesised that Nedd4 may be
regulating the expression of these core NC maintenance and survival
factors. To test this notionwe analysed expression of Sox10, FoxD3 and
Snail, in primary NC and NC-U-10-K cells following Nedd4 siRNA
knockdown. Quantitative RT-PCR analysis showed that Sox10 and
FoxD3 were signiﬁcantly downregulated upon Nedd4 protein knock-
down in both cell systems (Fig. 7A). In contrast, Snail was only found
to be signiﬁcantly downregulated in NC-U-10-K cells. Western blot
analysis also demonstrated that Sox9 and Sox10 protein levels were
signiﬁcantly reduced in NC cells depleted of Nedd4 protein (Fig. 7B).
This was also conﬁrmed using immunoﬂuorescent microscopy; cells
that had been subjected to Nedd4 protein knockdown exhibited
dramatically reduced Sox9 and Sox10 protein levels in these cells
without affecting their localisation (Fig. 7C). Taken together, these
Fig. 7. Knockdown of Nedd4 in NC cells grown in vitro leads to a loss of NC maintenance markers. (A) Quantitative reverse transcription (RT) PCR for Sox10, FoxD3 and Snail in
NC-U-10-K cells (left panel) and primary NC cells (right panel) after treatment with control or Nedd4 siRNA. Relative expression levels were normalised to expression of
GAPDH and are represented as a fold change relative to expression levels in the control siRNA treated sample. Error bars represent standard error of the mean (SEM) and
P-values are based on a t-test. ****Po0.0001; **Po0.004; *P¼0.012. Snail fold change in primary NC cells had a P-value of 0.056. (B) Western blot analysis of NC-U-10-K cells
following Nedd4 knockdown using anti-Sox9 and anti-Sox10 antibodies. (C) Immunoﬂuorescent staining of NC-U-10-K cells following Nedd4 knockdown using anti-Sox9 and
anti-Sox10 antibodies. All images of Sox9 staining and Sox10 staining were taken at the same exposure. Scale bar¼100 μm.
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mRNA and protein expression analyses suggest that NC cells lose their
maintenance and cell survival capacity as a result of Nedd4 deﬁciency.
Nedd4 promotes NC stem-cell self-renewal
NC cells that delaminate from the neural tube exist as a
heterogeneous pool of fate speciﬁed and multipotent stem-cells.
As Sox9, Sox10 and FoxD3 also promote multipotent NC stem-cell
properties (John et al., 2011; Mundell and Labosky, 2011), our
ﬁndings raised the hypothesis that Nedd4 may regulate cranial NC
stem-cell dynamics. To address the role of Nedd4 in the self-
renewal properties of NC stem-cells we turned to a neurosphere
culture assay in which neural tube derived primary NC cells are
grown in conditions that promote stem-cell maintenance. NC cells
from wildtype E8.5-9.5 cranial or trunk neural tube explants were
passaged and grown under non-adherent conditions to promote
neurosphere formation. Consistent with previous reports we
found that around 0.5% of dissociated primary NC cells formed
neurospheres in our control assays from both sources (John et al.,
2011). Nedd4 siRNA treated cells formed signiﬁcantly fewer neuro-
spheres (n¼3, 50% of control, p¼0.017) that were also smaller in
size (n¼3, 70% of control, p¼0.007; Fig. 8A and B). This reduction
in neurosphere number and size was not merely a result of cells
dying upon Nedd4 siRNA knockdown, as inhibition of cell death
with the caspase inhibitor Z-VAD-FMK did not rescue neurosphere
number or size (Fig. 8C). Taken together, this indicates that loss of
Fig. 8. Loss of Nedd4 reduces the stem-cell maintenance capacity of NC cells. (A) NC cell neurospheres grown for 5 days after treatment with either control or Nedd4 siRNA.
Scale bar¼100 μm. (B) Graphs represent quantitation of neurosphere number and size from three independent experiments. Relative neurosphere number and size is
expressed as a fold change relative to the control siRNA treated sample. Error bars represent standard error of the mean (SEM) and P-values are based on a t-test. **P¼0.007
and *P¼0.017. (C) Neurosphere formation was analysed following treatment with the caspase inhibitor Z-VAD-FMK. Relative neurosphere number is expressed as a fold
change relative to the control siRNA and vehicle (DMSO) treated sample. Z-VAD-FMK had no signiﬁcant effect upon rescuing neurosphere formation in Nedd4 siRNA treated
cells. Each treatment was performed in triplicate, error bars represent standard error of the mean (SEM) and P-values are based on a t-test. The data presented here is derived
from trunk NC cells. ***Po0.001 and ns¼not signiﬁcant.
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Nedd4 reduces the self-renewal capacity and proliferation of NC
stem-cells grown in culture.
Nedd4 promotes expression of NC maintenance and stem-cell
markers in vivo
We next investigated whether there was an equivalent loss of
NC maintenance and stem-cell markers in Nedd4/ embryos.
Neural tubes were explanted from both Nedd4 / and wildtype
controls, and allowed to grow for 48 h to promote NC cell
outgrowth. There was a similar degree of NC outgrowth from
neural tubes after 24 h from both genotypes. After 48 h these cells
were ﬁxed and stained with antibodies recognising NC mainte-
nance and stem-cell markers, p75 and Sox10. While NC cells from
the control embryo migrated away from the neural tube and
maintained their expression of p75 and Sox10, NC cells from
Nedd4/ embryos initially expressed p75 and Sox10 while still
in close proximity to the neural tube, however cells that had
migrated away more distally tended to lose expression of these
markers (Fig. 9A).
To investigate whether loss of NC maintenance factors in
Nedd4/ NC cells occurs prior to cell death, or conversely
whether Nedd4 / NC cells begin to undergo apoptosis and
subsequently lose maintenance / cell survival marker expression,
we performed Nedd4 siRNA knockdown on wildtype neural tube
explants in the presence or absence of the caspase inhibitor
Z-VAD-FMK. Similar to explants from Nedd4 / neural tubes
(see Fig. 9A), Nedd4 siRNA knockdown caused a marked reduction
in Sox10 expression (Fig. 9B). This reduction was still apparent
when neural tubes were treated with the caspase inhibitor Z-VAD-
FMK (Fig. 9B), indicating that with loss of Nedd4, NC cells lose
their NC maintenance and self-renewal capacity prior to cell death.
Our ex vivo analyses suggest an essential role for Nedd4 in the
process of NC cell maintenance, survival and self-renewal during
NC development. We next explored this notion by analysing the
expression of Sox9 and Sox10 in Nedd4/ embryos at E9.5
(Fig. 10). Our analysis indicates that Sox9 and Sox10 are distinctly
downregulated in cranial NC cells of the r1 and r2 stream (Fig. 10A
arrowhead and Fig. 10B). Co-staining of transverse sections
through the r2 region with anti-Sox10 and anti-cleaved caspase
3 further demonstrates that in the absence of Nedd4 a subset of
cranial NC cells aberrantly lose expression of Sox10 (Fig. 10B).
Moreover, those cells with reduced Sox10 concurrently induce
expression of cleaved-caspase 3 (arrows) and undergo apoptosis.
These results reinforce our hypothesis that cranial NC cells in
Nedd4 / embryos are initially speciﬁed and delaminate from the
neural tube in a normal manner, however, after leaving the neural
tube, these cells progressively lose their NC survival factors and
self-renewal capacity.
Discussion
Apart from the general indication that ubiquitination is active
in NC cells in the chick (Smith-Thomas et al., 1994) there have
been no previous reports detailing an essential role for ubiquitin
ligases in mammalian NC cell development (Wiszniak et al., 2013).
In mice, the ubiquitin ligase Wwp2 is expressed in condensing
cartilage to control craniofacial formation, however, a role in NC
cell development was not investigated (Zou et al., 2010). Using
Fig. 9. Loss of Nedd4 leads to loss of stem cell markers prior to cell death. (A) Neural tube explants from Nedd4þ /þ and Nedd4/ E9.5 embryos were grown ex vivo to allow
NC cell outgrowth. NC cells were stained with anti-p75 and anti-Sox10 antibodies. Arrowheads indicate cells that have lost expression of p75 and Sox10. (B) Neural tube
explants from wildtype E9.5 embryos were grown ex vivo, and treated with control or Nedd4 siRNA, and vehicle (DMSO) or Z-VAD-FMK. NC cells were stained with anti-
cleaved-caspase 3 and anti-Sox10 antibodies. Inhibition of Caspase activity did not rescue the loss of stem cell markers upon Nedd4 knockdown.
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functional mouse genetics, expression analyses and the ex vivo
culture of primary NC cells, we now uncover an essential role for
the ubiquitin ligase Nedd4 as a positive regulator of the core
transcription factors, Snail, Sox9, Sox10 and FoxD3 to maintain the
survival and stem-cell characteristics of a subset of cranial NC cells.
When these maintenance signals are lost in Nedd4 deﬁcient
embryos, a proportion of cranial NC cells undergo apoptosis.
Notably, aberrant NC cell apoptosis has also been described in
FoxD3, Sox9 and Sox10 deﬁcient mice (Cheung and Briscoe, 2003;
Kapur, 1999; Sonnenberg-Riethmacher et al., 2001; Southard-
Smith et al., 1998; Teng et al., 2008). We propose that this aberrant
cell death results in an insufﬁcient population of cranial NC cells
that impacts on formation of the craniofacial skeleton and cranial
ganglia (see model in Supplementary Fig. S6).
Rather than playing a role in cranial NC speciﬁcation or delamina-
tion, our data best support a model inwhich Nedd4 has a primary role
in maintaining the survival and promoting stem-cell like properties of
a proportion of cranial NC cells (Supplementary Fig. S6). Firstly, we
found that Nedd4 expression is hightened in cranial NC cells compared
to surrounding tissues at E9.0-9.5 (Fig. 3). Secondly, we found that
Fig. 10. Nedd4 / embryos exhibit loss of stem cell markers prior to cell death in vivo (A) Confocal images of control and Nedd4/ E9.5 embryos stained with anti-Sox9
antibody in wholemount (upper panels) or transverse section through rhombomere 2 (r2) (bottom panels). The arrowhead indicates reduced Sox9 staining in the
mesenchyme below r1 and r2 in mutant embryos. (B) Confocal images of control and Nedd4/ E9.5 transverse sections through r2 stained with anti-Sox10 and activated
caspase-3 antibodies. Sox10 is reduced in the NC cell stream in Nedd4 / embryos. Arrows highlight NC cells with low expression of Sox10 undergoing apoptosis. e, eye.
Scale bar¼500 μm.
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there was cranial NC cell hypoplasia in Nedd4 / embryos (Fig. 4) in
the absence of structural defects in the midbrain/hindbrain or gross
defects in cranial NC induction (Fig. 5). Thirdly, although we identiﬁed
a minimal amount of cell death in the neural tube, the majority of
apoptotic cells were located in cranial NC cells in the facial primordia,
corresponding to the regions of the frontonasal prominence, maxillary
prominence, mandibular prominence and the anlage of the trigeminal
ganglia (Fig. 6) in which the NC cell hypoplasia was also most evident.
Finally, we also found that in the absence of other cell types, Nedd4-
knockdown NC cells rapidly lose expression of these core NC main-
tenance transcription factors (Fig. 7) and aberrantly apoptose. Taken
together our analyses therefore suggest that some of the craniofacial
and cranial ganglia defects in older Nedd4 / embryos may arise from
deﬁciency of a subset of cranial NC cells. Our ﬁndings of heightened
Nedd4 expression in migrating cranial NC cells and excessive apoptosis
in ex vivo Nedd4-KD cranial NC cells also support a model where
Nedd4 plays a cell autonomous role in NC cell development. However,
as Nedd4 expression is not restricted to the NC, we are currently
unable to determine if some of the cranial NC deﬁciencymay also arise
from extrinsic effects from other interacting cell types. Future studies
taking advantage of conditional mouse knockouts will be useful in
addressing this issue.
As our analyses of older embryos identiﬁed deﬁciencies of bone
formation in the head we carefully considered that this may arise from
a general growth delay as a result of the reported IGF signalling
deﬁciency in Nedd4 / mice (Cao et al., 2008). At E12.5 we found that
cranial NC condensation into Sox9 positive cartilage is similar between
Nedd4 / and wildtype controls. However, the condensation of
Runx2 positive bone was almost completely absent at the same time.
This predominant defect in bone formation, and near normal devel-
opment of cartilage, was also evident at E15.5 and E17.5. Of note,
chondrogenic staining was comparable between Nedd4/ and con-
trols at E15.5, however, by E17.5 cranial NC derived bone was severely
affected in Nedd4/ embryos. As non-NC derived bone is affected to
a lesser extent than NC-derived bone (for example, although smaller,
the exoccipital, bassioocipital and vertebrae are forming in Nedd4/
embryos compared to controls) this suggests that rather than being a
developmental delay, the cranial NC cell hypoplasia at earlier stages of
development impacts on bone formation at later stages of develop-
ment. Indeed, our quantitation of craniofacial bones identiﬁed pre-
dominant deﬁciencies of NC-derived bone over and above that of
paraxial mesoderm derived bone. Since the cartilage in the head
appears mostly unaffected in Nedd4 / embryos at all time points
examined, our ﬁndings raise the hypothesis that Nedd4 may be
preferentially required for cranial NC cell bone formation rather than
cartilage formation. Several scenarios may be envisioned to explain
this phenomenon. Our ﬁnding that only a subset of cranial NC cells
undergoes apoptosis in Nedd4 deﬁcient embryos could suggest that
ectomesenchymal NC cells are pre-speciﬁed to become either bone or
cartilage at earlier stages of development. However, as intramembra-
nous bone formation only occurs after cartilage condensation, this
defect is more likely explained by a reduced pool of cranial NC cells
being unable to form the full extent of bone in mutant embryos.
Another possibility is that in addition to the role Nedd4 plays in
cranial NC cell survival, as suggested in this manuscript, Nedd4 may
also be essential for cranial bone formation later in development.
In support of this latter hypothesis, our analyses also identiﬁed minor
deﬁciencies of non-NC derived bone that suggests Nedd4 may have a
general role in osteogenesis. Consistent with this notion Nedd4 is
expressed at the correct time and location to play a role in endochon-
dral bone formation in the limb (Weston and Underhill, 2000).
A detailed investigation into the expression and function of Nedd4
at later stages of cranial ossiﬁcation will help to clarify these
possibilities.
In addition to the preferential role of Nedd4 in cranial bone
formation, our analysis of the paired cranial ganglia adds to the
notion that Nedd4 is required only in a speciﬁc subset of cranial
NC cells. Thus, although Nedd4 is expressed in both the r2 and r4
NC cell streams, deﬁciencies were only identiﬁed in the r2 stream
and the trigeminal ganglia that are populated from these cells.
As the Nedd4 / mice used in this study are complete null
(Cao et al., 2008), these defects are unlikely to result from a partial
KO of Nedd4 in only some cells. Although the reason why Nedd4 is
required in only a subset of cranial NC cells remains unknown, it is
possible that other E3 ligases may act redundantly with Nedd4, or
that Nedd4 or its targets are differentially expressed within cranial
NC cells.
Our ﬁnding of aberrant cell death in Nedd4 / embryos provides
a cell-based mechanism for the NC-derived craniofacial deﬁciency in
older embryos. Moreover, our ﬁnding of reduced Sox9, Sox10, Snail
and FoxD3 provides insight to the molecular defects underpinning
aberrant cranial NC cell death. As Nedd4 is an E3 ubiquitin ligase that
regulates the stability or function of target proteins, its impact on the
expression of these core NC transcription factors is likely to be
indirect. Using our NC cell culture systemwe have so far been unable
to identify notable changes in abundance or cell localisation of a
number of the putative Nedd4 targets implicated in NC cell develop-
ment, such as FGFRs, IGFR, and ErbB receptors (SW and QS,
unpublished data). Of note, Nedd4 has been suggested to modulate
several signalling pathways that may help to explain our ﬁndings of
reduced Sox9 and Sox10 expression. In Drosophila, Nedd4 is proposed
to positively regulate hedgehog signalling through targeting Ptch (Lu
et al., 2006). As the hedgehog pathway positively regulates activity
and expression of Sox9 in neural stem-cells (Scott et al., 2011), this
suggests a possible link between Nedd4 and Sox9 via hedgehog
signalling. In premyoblast C2C12 cells, Nedd4 negatively regulates
TGFβ signalling through targeting the receptor-regulated SMAD,
SMAD1 (Kim et al., 2011). As TGFβ has been found to down-
regulate Sox10 in NC cells (John et al., 2011) this also suggests a
possible link between Nedd4 and Sox10. It is also of note that one of
the established in vivo targets of Nedd4, IGFR1, has recently been
suggested to play a role in NC cell development through the control of
migration and differentiation (Onuma et al., 2011; Schofer et al.,
2001). We envisage that the phenotype of Nedd4/ mice is likely the
result of a combinatorial effect of changes to the function and/or
abundance of many proteins, and not the result of perturbances to a
single substrate. Future investigations to identify the Nedd4 sub-
strates in NC cells will therefore help to understand the fundamental
mechanisms controlling cranial NC cell maintenance, speciﬁcation
and differentiation. Although Nedd4 primarily functions as an E3
ligase, it is also possible that this protein may play a non-E3 ligase role
as recently suggested in another study (Kalinichenko et al., 2012).
However, the fact that the disturbances to development of the cranial
NC, trigeminal ganglia and NC derived cranium are so striking in
these mice, genuinely highlights the pivotal role Nedd4 plays in
cranial NC development.
Our analyses of Nedd4 / embryos and Nedd4 KD NC cells suggest
that Nedd4 plays an essential role in maintaining cranial NC cell
survival and stem-cell like properties by promoting expression of
Sox9, Sox10 and FoxD3. Indeed, the ﬁndings that Sox9, Sox10 and
FoxD3 are dispensible for the early stages of NC development but
required for maintenance of NC cells during or post delamination
(Cheung and Briscoe, 2003; Kapur, 1999; Sonnenberg-Riethmacher
et al., 2001; Southard-Smith et al., 1998; Teng et al., 2008) add strong
support to this notion. Our phenotypic analysis also identiﬁed
important differences between the NC phenotypes of Nedd4/ and
Sox9, Sox10 and FoxD3 KO animals. Unlike the requirement of these
transcription factors in the vast majority of all NC populations, our
study found that Nedd4 is required in only a subset of cranial NC cells.
Whether a role for Nedd4 also extends to additional NC populations
has not been assessed in this work and is currently unknown. While
the reduced size of the trigeminal ganglia in Nedd4/ embryos is
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similar to that reported in Sox10 and FoxD3 KO mice (Herbarth et al.,
1998; Teng et al., 2008), the craniofacial phenotypes of Sox9 and
FoxD3 KO animals are quite different (Mori-Akiyama et al., 2003; Teng
et al., 2008). Whereas Sox9 mutants have complete absence of all
cranial NC derived cartilage (Mori-Akiyama et al., 2003), FoxD3
mutants have profound clefting of the face and palate that result
from the absence or hypolplasia of many craniofacial structures (Teng
et al., 2008). The disparity between these mouse mutants and that
presented here likely arises from the requirement of Nedd4 in only a
subset of cranial NC cells and that the lack of Nedd4 only partially
reduces the expression of these core transcription factors.
A small proportion of NC cells delaminating from the neural
tube are likely to represent stem-cells with the ability to form
multiple derivatives under the instruction of target derived sig-
nals. Indeed, the identiﬁcation of NC stem-cells in adult tissues, in
ex vivo clonal culture experiments, and in transplantation experi-
ments (Barofﬁo et al., 1991; Bronner-Fraser and Fraser, 1988;
Bronner-Fraser et al., 1980; Crane and Trainor, 2006; Delﬁno-
Machin et al., 2007; Ito and Sieber-Blum, 1991; Sieber-Blum and
Cohen, 1980; Trentin et al., 2004) strongly suggest that at least
some NC cells start as, and remain stem-cells during development.
Recent ﬁndings have shown that Sox10 and FoxD3 are required for
the self-renewal and multipotentiality of NC stem-cells grown in
culture (Kim et al., 2003; Mundell and Labosky, 2011). To explore a
potential role for Nedd4 in maintaining NC stem-cell like
dynamics, here we have analysed its ability to promote the self-
renewal capacity of cranial NC cells. Our ﬁnding that Nedd4-KD
cranial NC cells form fewer neurospheres that are also smaller
suggests that Nedd4 promotes expression of Sox10 and FoxD3 to
promote cranial NC stem-cell like proliferation and self-renewal.
Given the lack of gross NC proliferation defects in vivo, this
proliferation defect may be restricted to the small proportion of
NC stem-cells. Although we have not yet completed a detailed
analysis of multipotentiality in Nedd4-KD NC cells, our quantita-
tive RT-PCR analysis after 2 days of siRNA KD suggests that
differentiation markers of myoﬁbroblasts are increased (SW, SK
and QS, unpublished data) similar to that reported in the absence
of FoxD3 (Mundell and Labosky, 2011). It will now be of interest to
deﬁne the differentiation potential of Nedd4-deﬁcient NC cells to
determine if Nedd4 also plays a role in fate speciﬁcation.
Other than the intrinsic roles of Sox9, Sox10 and FoxD3
(Cheung and Briscoe, 2003; Kim et al., 2003; Mundell and
Labosky, 2011; Scott et al., 2011), and the synergistic effects of
Wnt and BMP signalling (Kleber et al., 2005), few factors that
mediate maintenance of NC cells and NC stem-cell properties have
been identiﬁed. Our ﬁnding that Nedd4 deﬁcient cranial NC cells
rapidly lose their stem-cell characteristics and aberrantly apop-
tose, identiﬁes Nedd4 as an essential molecule in cranial NC cell
maintenance. Finally, it is also unclear which signalling pathways
regulate the expression of these core NC transcription factors.
Gain-of-function and loss-of-function studies in chick suggest that
the expression of at least two of these factors, Sox9 and FoxD3, are
regulated in parallel by independent signalling pathways (Cheung
et al., 2005). Our ﬁndings therefore suggest that Nedd4 may play
an essential role in cranial NC cell development by integrating
multiple signalling pathways to coordinate the expression and
function of several transcription factor networks.
Materials and methods
Mouse strains
Nedd4 / mice have been described previously (Cao et al.,
2008). Genotyping for Nedd4 wildtype and mutant alleles was
performed on genomic DNA using the following primers: wildtype
forward 5′-TCTTATGGGTGCTGTGGTTACAG-3′; wildtype reverse 5′-
CATGTGCTTTACCACTGAGC-3′; mutant forward 5′-CCTTGCAAAA
TGGCGTTACT-3′; mutant reverse 5′-CATGTGCTTTACCACTGAGC-3′.
In all experiments, embryos labelled as ‘control’ are either
Nedd4þ /þ or Nedd4þ / littermates, of which there was no
distinguishable phenotypic difference. Wildtype CD1 mice were
used to obtain E9.5 embryos to generate primary NC cells for
Nedd4 knockdown studies. All animal work was conducted in
accordance with the guidelines of the SA Pathology/CHN and the
University of Adelaide Animal Ethics Committees.
Skeletal preparations
Alcian blue and Alizarin red staining of cartilage and bone was
performed as described by Nagy et al. (2003).
Histology and immunolabelling
Embryos were ﬁxed in 4% paraformaldehyde in PBS. E15.5
embryos for palatal shelf analysis werEcryosectioned and stained
with haematoxylin and eosin (H&E) using standard procedures.
For immunolabelling, cryosections or wholemount embryos were
blocked in 10% goat serum, 0.2% BSA, 0.2% Triton X-100 in PBS, and
stained with the indicated primary antibodies overnight at 4 1C.
For staining of NC-U-10-K cells and primary NC explants, cells
were blocked in 0.2% BSA, 0.2% Triton X-100 in PBS. Antibodies
used: mouse anti-BetaIII tubulin (Sigma) 1:750; rabbit anti-Sox9
(Millipore) 1:1000; rabbit anti-p75 (Epitomics) 1:200; mouse anti-
p75 (Biosensis) 1:200; rabbit anti-cleaved caspase 3 (Cell Signal-
ling Technology) 1:500; goat anti-Sox10 (Santa Cruz) 1:200; and
rabbit anti-phospho-Histone H3 (Cell Signalling Technology)
1:500. Cyrosections and cells were mounted in Prolong Gold
antifade reagent with DAPI (Molecular Probes). High resolution
images were recorded on an IX81 inverted microscope (Olympus)
equipped with an OCRA-ER digital CCD camera (Hamamatsu) and
processed with CellR software (Olympus). Confocal images were
acquired on a LSM 700 (Zeiss) system. All ﬁgures were constructed
in Adobe Photoshop CS3 (Adobe Systems, Inc.).
In situ hybridisation
Wholemount and section in situ hybridisation was performed
as described (Schwarz et al., 2004). Riboprobes were transcribed
from plasmids containing cDNA sequences for cadherin 6, RunX2,
Sox10, Krox20, HoxB1, Crabp1, Wnt1 and Fgf8. For each probe,
control and Nedd4 / embryos were developed for the same
amount of time. Low resolution images were recorded on an
SZX10 stereo microscope (Olympus) equipped with a Micropubl-
isher 3.3 digital camera (Q-Imaging) and processed with OpenLab
2.2 software (Improvision).
Quantitative RT-PCR
Total RNAwas isolated from cells using Trizol (Ambion) and single
stranded cDNA was synthesised using the QuantiTect Reverse tran-
scription kit (Qiagen). qPCR was performed with SYBR Green reagent
(Qiagen) using the Rotor-Gene 6000 real-time PCR system (Corbett
Life Science). Primers used were as follows: Nedd4 F: GTGGATGCTGG-
GAGTTGAAT, R: TTTGTCTGCACGCTGGTAAG; Sox10 F: GGAGGCA-
GAATGCCCAGGCG, R: TGGCTCTGGCCTGAGGGGTG; FoxD3 F: CCAGGC
GGTACGCCCTCTCT, R: CAGCGGACGCGGGTTGAGTT; Snail F: CCACTG-
CAACCGTGCTTTT, R: CACATCCGAGTGGGTTTGG; GAPDH F: ACCCAGA
AGACTGTGGATGG, R: CAGTGAGCTTCCCGTTCA. Relative mRNA levels
were quantiﬁed using the comparitive quantitation method in Rotor-
Gene 6000 Series Software. Relative mRNAs levels were then normal-
ised to GAPDH mRNA levels. Each PCR was performed in technical
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triplicates, and each experiment was performed in at least three
biological replicates. Error bars represent standard error of the mean
(SEM) between biological replicates.
Western blotting
Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris pH
7.4, 1% Triton X-100, 0.1% SDS, and 0.5% Deoxycholate) containing
Complete Protease Inhibitors (Roche). Protein samples were sepa-
rated by SDS-PAGE and transferred to Amersham Hybond-P PVDF
membrane (GE Healthcare). Membranes were blocked in 2% skim
milk powder in TBS with 0.1% Tween 20. The following primary
antibodies were used: mouse anti-Nedd4 (BD Biosciences) 1:1000;
mouse anti-α-tubulin (Abcam) 1:5000; rabbit anti-Sox9 (Milli-
pore) 1:1000; rabbit anti-Sox10 (Epitomics) 1:500; and mouse
anti-β-actin (Sigma) 1:5000. Secondary antibodies used were:
donkey anti-mouse-HRP (Jackson ImmunoResearch) 1:5000
and donkey anti-rabbit-HRP (Jackson ImmunoResearch) 1:5000.
Membranes were analysed using Amersham ECL Prime reagent
(GE Healthcare) and LAS4000 detection equipment.
Cell culture
Neural tubes were isolated using modiﬁcations to the method
of Stemple and Anderson (1992). The neural tube area in the
cranium or last 10 somites of the trunk were micro-dissected from
the back of E8.5 embryos or E9.5 embryos, respectively, and
dissociated from surrounding tissue with enzymatic digestion
by incubating at room temperature for 10 min with 1 mg/ml
neutral protease (Worthington) and 0.002% Deoxyribonuclease
(Worthington) for 5 min. Dissected neural tubes were explanted
onto 50 mg/ml ﬁbronectin (Roche) coated hydrophobic 35 mm
culture dishes (IBIDI) and cultured for 48 h at 37 1C with 5% CO2
in medium containing 5% chicken embryo extract (CEE), 2% B27
(Invitrogen), 1% N2 (Invitrogen), 20 ng/ml insulin-like growth
factor (IGF) 1 (R&D Systems) and Dulbecco's modiﬁed Eagle's
medium (DMEM) low glucose F12 media (Invitrogen). For siRNA
knockdown studies of passaged NC cells the cells were dissociated
using Tryple Express (Gibco) and 1104 cells plated per well of an
8-well μ-slide (IBIDI). For knockdown studies of neural tube
explants siRNA was added at the time of plating. siRNA transfec-
tions were performed using RNAimax (Invitrogen) and Nedd4
Stealth siRNA (Invitrogen) or low GC control siRNA (Invitrogen).
For neurosphere assays, NC cells were dissociated with papain, and
plated at 1104 cells per 24-well Ultra-Low Attachment plate
(Costar) for formation of primary neurospheres. For secondary
neurosphere formation, primary neurospheres were dissociated
with papain and 3103 cells plated per well. Neurospheres were
cultured in media containing 30% CEE, 30% Neurobasal medium
(Invitrogen), 2% N2, 1% B27, 10 mM HEPES, 20 ng/ml IGF1, 20 ng/ml
EGF (R&D Systems), 20 ng/ml FGF (R&D Systems), 50 μM β-
mercaptoethanol (Sigma) and DMEM F12 medium. NC-U-10-K
cells were cultured in DMEM containing 10% foetal bovine serum,
and were treated with siRNAs as described above.
microCT Scans
Whole embryos were collected and ﬁxed in 95% EtOH for 2 days
prior to the removal of excess soft tissue. Ex vivo micro-CT was
performed on whole embryos using a micro-CT system (Skyscan
1076, Brussels, Belgium) at a resolution of 9.2 μm/pixel. Recon-
structed X-ray images were realigned to generate 3D projections
that were rotated to form dorsal and lateral views. To calculate
bone density a region of interest (ROI) was formed around the
cranial NC derived bone, body or humerus for analyses using CTan
software (v.1.9.1.0, Skyscan, Belgium). 3D analysis of the ROI gave
rise to several quantitative bone parameters including bone
volume, surface area and bone density. Bone density of the cranial
bones and body were determined by calculating the percentage of
bone volume/tissue volume and normalised to the density of the
humerus in each genotype.
β-Galactosidase staining
Whole embryos or cryosections were incubated in staining
solution: 19 mM Sodium dihydrogen phosphate, 81 mM Disodium
hydrogen phosphate, 2 mM MgCl2, 5 mM EGTA, 0.01% Sodium
deoxycholate, 0.02% NP-40, 5 mM Potassium ferricyanide, 5 mM
Potassium ferrocyanide and 1 mg/ml X-gal substrate, at 37 1C until
blue staining was sufﬁcient.
TUNEL staining
TUNEL staining was performed using the TMR Red in situ Cell
Death Detection Kit (Roche), following the manufacturers
recommendations.
Live-cell imaging and cell death assay
Imaging was performed using the IncuCyteTM Live-Cell Imaging
System (Essen BioScience). Cell conﬂuency (%) was calculated
using IncuCyteTM software. For cell death analysis, cells were
treated with CellPlayer kinetic Caspase 3/7 reagent (Essen
Bioscience) at the time of siRNA knockdown, and phase contrast
and ﬂuorescent images were acquired every 60 min. IncuCyteTM
imaging software was used to calculate the number of ﬂuorescent
objects per millimetre square as a measure of apoptosis. This value
was normalised to the cell conﬂuency (in %) of the same area of
the image, to give the number of apoptotic cells per % conﬂuency.
Inhibition of caspase activity
Z-VAD-FMK (Promega) was added to neurospheres or neural
tube explants at the time of plating at a ﬁnal concentration of
50 μM.
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